Journal of Cancer Research and Therapeutics

: 2015  |  Volume : 11  |  Issue : 7  |  Page : 27-

Demography and Education


Correspondence Address:

How to cite this article:
. Demography and Education.J Can Res Ther 2015;11:27-27

How to cite this URL:
. Demography and Education. J Can Res Ther [serial online] 2015 [cited 2020 Aug 4 ];11:27-27
Available from:

Full Text

Abstract: 006

Status of medical physics education in India

thVindhyavasini Pandey

Bhaba Atomic Research Centre, Mumbai, Maharashtra, India, E-mail:

In India, medical physics activities started in the mid 40s with the appointment of Dr. Ramaiah Naidu as the first medical physicist at the Tata Memorial Hospital, Mumbai with the responsibility to set up and operate a radon plant for cancer treatment. Cancer Burden in India: 1 million new cases/year Technological aspect of medical physics: Linear accelerators - 380, Tomotherapy - 5, Cyberknife - 4, Cobalt units - 190, Brach therapy units HDR - 250 LDR - 100 Manual - 90, Total Licenced RT centers in India-340 As per the WHO recommendation for the present population nearly 1600-1800 machines are required. Classification based on techniques performed: Indigenous manufacturer of teletherapy unit: (1) Bhabha Atomic Research Centre, Mumbai (telecobalt & brachytherapy unit) Bhabhatron-I/II ( (2) Sameer, IIT Mumbai (LINAC) Siddharth (6/15 MeV) ( (3) Panacea medical technologies, Bangalore ( educational aspect of medical physics. BARC with support from WHO started one year post graduate Diploma in Radiological Physics since 1962. Till 1982 this was the only training programme with capacity of 20 trainees available to get Qualified Medical Physicists. To cater the to the need of rising demand of Medical Physicist - Anna University in Collaboration with Adyar Cancer institute started 2 years M.Sc. Programme started in 1970. In India at present two pathways two become Qualified Medical Physicist [QMP] (1) One year post M.Sc. [Physics] Diploma in Radiological Physics [Dip. R.P] from BARC Deemed University {HBNI} (2) Two years post graduate degree course in Medical Physics after graduation in science.

Abstract: 196

Incidence of second primary malignant neoplasm: A study from cancer centre in central India

thA. Naik , V. Bhandari

Sri Aurobindo Medical College and Post Graduate Institute, Indore, Madhya Pradesh, India, E-mail:

Background: Increase in survival rates either due to early diagnosis or better treatment modalities have resulted in an increase in number of long term cancer survivors which exposes them to risk of developing a second primary malignancy (SPM). As cancer patients having 20% higher risk of developing a new primary cancer than general population and overall survival rates reaching 66% for all cancer patients, incidence of SPM is on rise. Aim: To identify incidence and other epidemiological data, risk factors and treatment related factors responsible for development of the SPM. Materials and Methods: Retrospective analysis of data of 7709 patients who visited department of oncology at our institute from May 2008 to August 2015 was done. All patients were looked for presence of SPM. Warren and Gates criteria is used for diagnosis of SPM. Tumor which were suspected to be a metastasis of the first location and tumors without histopathological confirmation are excluded. Data pertaining age at diagnosis of each tumor, gender and sex, synchronous or metachronous, site of origin, histology, interval duration, treatment given, clinical course and smoking status, survival after diagnosis and metastasis site were recorded. Results: SPM was observed in 56 patients over period of 8 years corresponding to a overall incidence of 0.726% of which 11 were synchronous and 45 were metachronous. For metachronous SPM interval of 10 month to 312 months was observed, with mean time before diagnosis is 103.32 months (S.D 65.9 months). Of these 29 were male and 27 were female with male to female ratio of 1.07. The median age of diagnosis for first primary neoplasm was 50 years (range 28-85 years) and that of second primary neoplasm was 57 years (range 34-85 years). The median age of diagnosis of first primary cancer was 50 and 49.5 years and for second primary cancer was 62 and 56 years for male and female respectively. Out of 56 patients, most number of SPM observed in head and neck region (33.93%) followed by breast (26.78%), gynecological tumors (8.93%) and genitourinary tumors (7.14%). Conclusion: Possibility of SPM should always be considered during pretreatment evaluation and careful monitoring should be done during follow-up of treated patients. Patients having breast cancer and head and neck region are at higher risk of developing SPM. Besides Treatment related factors other factors also plays a role in development of SPM.